| Immunogenic cell death and DAMPs in cancer therapy | 2012/11/15 | English | 1,808 |
| Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy | 2016/04/15 | English | 1,803 |
| A framework for advancing our understanding of cancer-associated fibroblasts | 2020/01/24 | English | 1,797 |
| Regulatory networks defining EMT during cancer initiation and progression | 2013/01/24 | English | 1,776 |
| The molecular biology of head and neck cancer | 2010/12/16 | English | 1,771 |
| Signal integration by JNK and p38 MAPK pathways in cancer development | 2009/08/01 | English | 1,767 |
| ATM and related protein kinases: safeguarding genome integrity | 2003/03/01 | English | 1,766 |
| HSP90 and the chaperoning of cancer | 2005/09/20 | English | 1,765 |
| Targeting PI3K signalling in cancer: opportunities, challenges and limitations | 2009/08/01 | English | 1,739 |
| The STATs of cancer — new molecular targets come of age | 2004/02/01 | English | 1,690 |
| The development of androgen-independent prostate cancer | 2001/10/01 | English | 1,663 |
| Cancer and the chemokine network | 2004/07/01 | English | 1,646 |
| Artificial intelligence in radiology | 2018/05/17 | English | 1,622 |
| Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer | 2006/01/01 | English | 1,616 |
| Targeting autophagy in cancer | 2017/07/28 | English | 1,612 |
| Paradoxical roles of the immune system during cancer development | 2006/01/01 | English | 1,579 |
| Neuroblastoma: biological insights into a clinical enigma | 2003/03/01 | English | 1,558 |
| Breast cancer metastasis: markers and models | 2005/08/01 | English | 1,552 |
| Mitochondria and cancer | 2012/09/24 | English | 1,550 |
| AP-1: a double-edged sword in tumorigenesis | 2003/11/01 | English | 1,548 |
| Dysregulated pH: a perfect storm for cancer progression | 2011/08/11 | English | 1,546 |
| Topoisomerase I inhibitors: camptothecins and beyond | 2006/10/01 | English | 1,546 |
| Hyaluronan: from extracellular glue to pericellular cue | 2004/07/01 | English | 1,517 |
| Liquid biopsies come of age: towards implementation of circulating tumour DNA | 2017/02/24 | English | 1,517 |
| High interstitial fluid pressure — an obstacle in cancer therapy | 2004/10/01 | English | 1,491 |
| Epstein–Barr virus: 40 years on | 2004/10/01 | English | 1,471 |
| Polymer conjugates as anticancer nanomedicines | 2006/08/10 | English | 1,467 |
| Immunosuppressive networks in the tumour environment and their therapeutic relevance | 2005/03/18 | English | 1,467 |
| Revisiting STAT3 signalling in cancer: new and unexpected biological functions | 2014/10/24 | English | 1,464 |
| Antibody therapy of cancer | 2012/03/22 | English | 1,462 |